Suppr超能文献

氟他胺口崩片的处方前研究与优化。

Formulation and optimization of orodispersible tablets of flutamide.

机构信息

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia ; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia ; Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt.

出版信息

Saudi Pharm J. 2014 Jan;22(1):53-61. doi: 10.1016/j.jsps.2013.01.009. Epub 2013 Feb 10.

Abstract

The present study aimed to formulate orodispersible tablets of flutamide (FTM) to increase its bioavailability. Orodispersible tablets were prepared by direct compression technique using three different approaches namely; super-disintegration, effervescence and sublimation. Different combined approaches were proposed and evaluated to optimize tablet characteristics. Sodium starch glycolate (SSG) was used as the superdisintegrant. The prepared powder mixtures were subjected to both pre and post compression evaluation parameters including; IR spectroscopy, micromeritics properties, tablet hardness, friability, wetting time, disintegration time and in-vitro drug release. IR studies indicated that there was no interaction between the drug and the excipients used except Ludipress. The results of micromeritics studies revealed that all formulations were of acceptable to good flowability. Tablet hardness and friability indicated good mechanical strength. Wetting and dispersion times decreased from 46 to 38 s by increasing the SSG concentration from 3.33 to 6.66% w/w in tablets prepared by superdisintegration method. The F8 formulation which was prepared by combined approaches of effervescence and superdisintegrant addition gave promising results for tablet disintegration and wetting times but failed to give faster dissolution rate. The incorporation of 1:5 solid dispersion of FTM: PEG 6000 instead of the pure drug in the same formulation increased the drug release rate from 73.12 to 96.99% after 15 min. This increase in the dissolution rate may be due to the amorphization of the drug during the solid dispersion preparation. The presence of the amorphous form of the drug was shown in the IR spectra.

摘要

本研究旨在制备非那雄胺(FTM)口崩片以提高其生物利用度。口崩片通过直接压片技术制备,采用三种不同的方法,即超崩解、泡腾和升华。提出了不同的组合方法并进行了评估,以优化片剂特性。交联聚维酮(SSG)用作超崩解剂。将制备的粉末混合物进行预压和后压评估参数,包括:红外光谱、微粉学特性、片剂硬度、脆碎度、润湿时间、崩解时间和体外药物释放。IR 研究表明,药物与所用辅料之间除 Ludipress 外无相互作用。微粉学研究结果表明,所有配方均具有可接受至良好的流动性。片剂硬度和脆碎度表明具有良好的机械强度。通过将超崩解方法中 SSG 浓度从 3.33%w/w 增加到 6.66%w/w,可将润湿和分散时间从 46 秒缩短至 38 秒。通过泡腾和超崩解剂联合添加制备的 F8 制剂在片剂崩解和润湿时间方面取得了有希望的结果,但未能实现更快的溶解速率。在相同制剂中加入 FTM:PEG 6000 的 1:5 固体分散体代替纯药物,可使药物在 15 分钟后的释放速率从 73.12%提高到 96.99%。这种溶出速率的增加可能是由于在固体分散体制备过程中药物的无定形化。药物的无定形形式在红外光谱中显示出来。

相似文献

1
Formulation and optimization of orodispersible tablets of flutamide.
Saudi Pharm J. 2014 Jan;22(1):53-61. doi: 10.1016/j.jsps.2013.01.009. Epub 2013 Feb 10.
2
Formulation Design and Optimization of Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method.
Indian J Pharm Sci. 2015 May-Jun;77(3):267-73. doi: 10.4103/0250-474x.159605.
3
Formulation and optimization of orodispersible tablets of diazepam.
AAPS PharmSciTech. 2010 Mar;11(1):356-61. doi: 10.1208/s12249-010-9387-y. Epub 2010 Mar 16.
6
Formulation of Ebastine Fast-Disintegrating Tablet Using Coprocessed Superdisintegrants and Evaluation of Quality Control Parameters.
ScientificWorldJournal. 2022 May 19;2022:9618344. doi: 10.1155/2022/9618344. eCollection 2022.
7
Preparation and evaluation of orodispersible tablets of pheniramine maleate by effervescent method.
Indian J Pharm Sci. 2009 Mar;71(2):151-4. doi: 10.4103/0250-474X.54284.

引用本文的文献

2
Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review.
Pharmaceutics. 2025 Jan 22;17(2):148. doi: 10.3390/pharmaceutics17020148.
5
Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 2-Factorial Design.
Pharmaceutics. 2022 Jul 14;14(7):1467. doi: 10.3390/pharmaceutics14071467.
6
Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives.
Biomed Res Int. 2021 Dec 24;2021:6618934. doi: 10.1155/2021/6618934. eCollection 2021.
9
Design and Characterization of Orally Disintegrating Modified Release Tablets of Naproxen Sodium.
Turk J Pharm Sci. 2020 Oct;17(5):486-491. doi: 10.4274/tjps.galenos.2019.24445. Epub 2020 Oct 30.
10
Formulation and in vitro Evaluation of Fast Dissolving Tablets of Febuxostat Using Co-Processed Excipients.
Recent Pat Drug Deliv Formul. 2020;14(1):48-62. doi: 10.2174/1872211314666191224121044.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验